Saskatoon, Canada

Deborah Michel

This inventor holds 1 USPTO granted patent. Top assignee: University of Saskatchewan. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deborah Michel. Retrieved from https://idiyas.com/inventor/deborah-michel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Drug Delivery: The Contributions of Deborah Michel

Introduction

Deborah Michel is a notable inventor based in Saskatoon, Canada. She has made significant contributions to the field of pharmaceutical sciences, particularly in drug delivery systems. Her innovative work focuses on enhancing the efficacy of drug delivery agents through novel chemical compositions.

Latest Patents

Deborah Michel holds a patent titled "Drug delivery agents comprising cyclodextrin covalently linked to a gemini surfactant, and pharmaceutical compositions comprising the same." This patent relates to cyclodextrin-based drug delivery agents that feature a cyclodextrin moiety covalently linked to a gemini surfactant moiety. The pharmaceutical compositions that include this drug delivery agent and a therapeutic agent are also disclosed in her patent. She has 1 patent to her name.

Career Highlights

Deborah Michel is affiliated with the University of Saskatchewan, where she conducts her research and development in drug delivery systems. Her work has garnered attention for its potential to improve therapeutic outcomes in various medical applications.

Collaborations

Some of her notable coworkers include Ildiko Badea and Ronald Verrall, who contribute to her research endeavors and collaborative projects.

Conclusion

Deborah Michel's innovative work in drug delivery systems exemplifies the importance of research in enhancing pharmaceutical efficacy. Her contributions continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…